EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Navigating the AI Transformation in Healthcare
Real Chemistrys expansion into Zurich is part of our broader objective to help clients by scaling internationally while maintaining a local mindset We are bringing our connected capabilities to one of Europes most influential hotspots sitting at the intersection of science innovation and investment This convergence is ideal for collaboration
Advisory Board
KNOWLEDGE BANK
-
Articles
Acquisitions of Small-Medium Pharma Companies in EU
In EU the middleclass in Pharma is disappearing companies with revenues by M with a small factory and operations limited to some few countries
Digital Health and Wearables: Integration with Pharmaceuticals for Improved Patient Outcomes
Digital health is the application of telecommunication technologies that allow people to control and maintain their health through their smartphone applications sensors and the cloud Mobile devices are while not the only ones an important factor in this digital health environment wearable fitness smart watches and health monitoring devices occupy this niche These wearables can track things as si...
Pre-Formulation Studies and Analytical Techniques in Pharmaceutical Formulation Development
Development of pharmaceutical formulations is a very important phase in the drug development process which lies between a drug molecule that is discovered and a dose form that can be commercially developed It is a process that involves designing optimizing and validating drug products to make sure that they are safe effective and able to be taken by patients Preformulation studies form a significa...
Virtual Webinars for Pharma Lead Generation: B2B Strategies 2026
In the changing environment of pharmaceutical marketing digital interactions have acquired the first place Although traditional facetoface conferences and trade show remain important virtual conferences are replacing them and at times complementing them Of them the pharma webinars have proven to be an effective approach to BB lead generation so pharmaceutical companies can connect with the audienc...
How Cloud Computing and AI Revolutionize Pharmaceutical Supply Chain Management
The pharma supply chain management has been considered as one of the most complicated spheres of operations in any industry As opposed to the traditional supply chain pharmaceutical supply chains have to juggle patient safety regulatory compliance cold chain integrity global sourcing and unpredictable demand and cost pressures simultaneously
How Drug Patents Shape the Competitive Landscape in Pharma?
It can rightly be said that the business of pharmaceuticals is very sensitive and crucial since business is all about the manufacturing of change for the purpose of ridding the world of diseases
-
Techno Trends
FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator
Calico Life Sciences LLC has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease a rare and progressive neurological disorder with no approved therapies
-
Projects
Johnson & Johnson Invests $1B to Expand U.S. Vision Manufacturing & Distribution
Johnson Johnson has announced an investment of more than billion to expand its Vision manufacturing operations in Jacksonville Florida The project is designed to increase domestic manufacturing packaging and distribution capacity for the company
-
Research Insights
Predicting unknown binding sites for transition-metal-based compounds in proteins
Transitionmetalbased compounds are promising therapeutic agents particularly in cancer treatment However predicting the binding sites of such compounds remains a major challenge In this work we investigate the applicabilit
-
whitepaper
Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch
Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities
TOP ARTICLES
-
1
Digital Health and Wearables: Integration with Pharmaceuticals for Improved Patient Outcomes
Harry Callum
Integrating a form of digital health and wearable technology is becoming increasingly beneficial in healthcare delivery since it provides real time monitoring, treatment, and results. Interlinked with...
-
2
Pre-Formulation Studies and Analytical Techniques in Pharmaceutical Formulation Development
Sarah Richards
Analytical methods and pre-formulation studies play a key role in the development of pharmaceutical formulations, as they give necessary information about the properties of the drug, excipient compati...
-
3
Virtual Webinars for Pharma Lead Generation: B2B Strategies 2026
Kate Williamson
Virtual webinars will become a standard element of the B2B pharma lead generation in 2026. The combination of targeted content and interactive interactions with data-based follow-ups enables pharmaceu...
-
4
How Cloud Computing and AI Revolutionize Pharmaceutical Supply Chain Management
Kate Williamson
One thing that the pharmaceutical supply chain management is going through is the implementation of cloud computing and artificial intelligence as a way of transforming the process. These technologies...
-
5
How Drug Patents Shape the Competitive Landscape in Pharma?
Kate Williamson
Drug patents are central in the pharmaceutical field because they offer marketing privileges over drugs, foster technological advancement, and control the market. They drive the research expenditure,...
press releases Read more...
Cytovance Biologics Expands Process Development Services with Perfusion Capabilities
Cytovance Biologics a leading USbased contract development and manufacturing organization CDMO serving the biopharmaceutical industry today announced the expansion of its upstream process development offerings with the addition of perfusion capabilities
Anova and Nouveau Biosciences Announce Partnership to Deliver Clinical Trials of Kromastat for the Treatment of Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphoma
Anova Enterprises Inc Anova a technology enabled CRO dedicated to accelerating promising treatments today announced its partnership with Nouveau Biosciences Inc to conduct cancer focused
Gerresheimer Commissions Photovoltaic System in Pfreimd
Gerresheimer an innovative system and solution provider and a global partner for the pharma biotech and cosmetic industries has successfully commissioned a photovoltaic system at its Pfreimd site following
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
Ligand Pharmaceuticals Incorporated Nasdaq LGND today announced it has completed its acquisition of XOMA Royalty Corporation XOMA Royalty a biotechnology royalty aggregator for per
Events Read more...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
26 - 30
Jul 2026ADLM 2026
Anaheim, CA USA
27 - 28
Jul 2026Pharmacovigilance & Drug Safety 2026
Rome, Italy
27 - 28
Jul 2026Pharmacology 2026
Rome, Italy
27 - 28
Jul 2026PharmaSci Innovations 2026
Rome, Italy
LATEST NEWS Read more...
Sinopia Biosciences Publishes Preclinical Study Supporting SB-0110 for Parkinson's Disease
Sinopia Biosciences has published preclinical research in Science Translational Medicine highlighting a new approach to treating Parkinsons disease The study supports the development of SB
Kairos Pharma Reports Positive Interim Safety Results from Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma has reported positive interim safety results from its ongoing Phase clinical trial of ENV carotuximab in combination with osimertinib Tagrisso for patients with advanced EGFRmutated nonsmall cell lung cancer NSCLC
FDA Grants Priority Review to Roche’s Gazyva/Gazyvaro for Primary Membranous Nephropathy
Roche has announced that the US Food and Drug Administration FDA has granted Priority Review to its supplemental Biologics License Application sBLA for GazyvaGazyvaro obinutuzumab as a treatment
FDA Grants Fast Track Designation to SOTIO’s SOT109 for Advanced Colorectal Cancer
SOTIO Biotech has received Fast Track Designation FTD from the US Food and Drug Administration FDA for SOT its investigational antibodydrug conjugate ADC for the treatment of patients
Armata Pharmaceuticals Secures FDA Agreement on Initial Paediatric Study Plan for AP-SA02
Armata Pharmaceuticals has received agreement from the US Food and Drug Administration FDA on its Initial Paediatric Study Plan iPSP for APSA supporting the future evaluation of the investigational
DA Approves LEQEMBI IQLIK Subcutaneous Injection for Early Alzheimer’s Disease Treatment
Eisai and Biogen have received approval from the US Food and Drug Administration FDA for a supplemental Biologics License Application sBLA for LEQEMBI IQLIK lecanemabirmb a onceweekly subcutaneous injection for the initiation treatment of early Alzheimers disease




